Rule SA - Search Results

1

Autoimmune haemolytic anaemia associated with mantle cell lymphoma.

Eve HE, Rule SA. Eve HE, et al. Among authors: rule sa. Int J Hematol. 2010 Mar;91(2):322-5. doi: 10.1007/s12185-009-0489-9. Int J Hematol. 2010. PMID: 20063131

2

Activity of thalidomide and lenalidomide in mantle cell lymphoma.

Richardson SJ, Eve HE, Copplestone JA, Dyer MJ, Rule SA. Richardson SJ, et al. Among authors: rule sa. Acta Haematol. 2010;123(1):21-9. doi: 10.1159/000257990. Epub 2009 Nov 12. Acta Haematol. 2010. PMID: 19907157

3

Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study.

Eve HE, Linch D, Qian W, Ross M, Seymour JF, Smith P, Stevens L, Rule SA. Eve HE, et al. Among authors: rule sa. Leuk Lymphoma. 2009 Feb;50(2):211-5. doi: 10.1080/10428190802688509. Leuk Lymphoma. 2009. PMID: 19197729 Clinical Trial.

4

Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.

Eve HE, Seymour JF, Rule SA. Eve HE, et al. Among authors: rule sa. Leuk Lymphoma. 2009 Mar;50(3):463-5. doi: 10.1080/10428190802641979. Leuk Lymphoma. 2009. PMID: 19197732 Clinical Trial. No abstract available.

5

Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.

Eve HE, Carey S, Richardson SJ, Heise CC, Mamidipudi V, Shi T, Radford JA, Auer RL, Bullard SH, Rule SA. Eve HE, et al. Among authors: rule sa. Br J Haematol. 2012 Oct;159(2):154-63. doi: 10.1111/bjh.12008. Epub 2012 Aug 9. Br J Haematol. 2012. PMID: 22881386 Free article. Clinical Trial.

6

The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial.

Eve HE, Gambell J, Smith P, Qian W, Rule SA. Eve HE, et al. Among authors: rule sa. Leuk Lymphoma. 2009 Oct;50(10):1709-11. doi: 10.1080/10428190903186494. Leuk Lymphoma. 2009. PMID: 19757310 Clinical Trial. No abstract available.

7

Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma.

Eve HE, Furtado MV, Hamon MD, Rule SA. Eve HE, et al. Among authors: rule sa. J Clin Oncol. 2009 Nov 10;27(32):e189-90; author reply e191. doi: 10.1200/JCO.2009.23.9731. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805667 No abstract available.

8

Lenalidomide-induced tumour flare reaction in mantle cell lymphoma.

Eve HE, Rule SA. Eve HE, et al. Among authors: rule sa. Br J Haematol. 2010 Nov;151(4):410-2. doi: 10.1111/j.1365-2141.2010.08376.x. Epub 2010 Sep 29. Br J Haematol. 2010. PMID: 20880113 Free article. No abstract available.

9

Does maintenance therapy have a role in mantle cell lymphoma treatment?

Parrott M, Rule S. Parrott M, et al. Expert Rev Hematol. 2018 Apr;11(4):285-292. doi: 10.1080/17474086.2018.1449635. Epub 2018 Mar 20. Expert Rev Hematol. 2018. PMID: 29521148 Review.

10

Ibrutinib for the treatment of mantle cell lymphoma.

Shah N, Hutchinson C, Rule S. Shah N, et al. Expert Rev Hematol. 2014 Oct;7(5):521-31. doi: 10.1586/17474086.2014.951323. Epub 2014 Aug 27. Expert Rev Hematol. 2014. PMID: 25158606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page